Related Experiment Video
Updated: Feb 11, 2026

Open Tracheostomy Gastric Acid Aspiration Murine Model of Acute Lung Injury Results in Maximal Acute Nonlethal Lung Injury
Published on: February 26, 2017
Nrf2 protects against acute lung injury and inflammation by modulating TLR4 and Akt signaling
Jia Yan1, Jingjie Li1, Lei Zhang1
1Department of Anesthesiology, Shanghai JiaoTong University School of Medicine, Center for Specialty Strategy Research of Shanghai Jiao Tong University China Hospital Development Institute, Shanghai Ninth People's Hospital, No. 639 Zhizaoju Road, Shanghai 200011, China.
Abstract:
Lung injury, which is associated with systemic inflammatory responses, is a common problem with significant morbidity and mortality. Here, we examined the involvement of toll-like receptor 4 (TLR4) and nuclear factor erythroid 2-related factor 2 (Nrf2) on intestinal ischemia-reperfusion (I/R)-induced lung injury in vivo and in vitro. Analysis of lung tissues in Nrf2-knockout mice by western blotting, immunohistochemistry, and TUNEL assay, and analysis of bronchoalveolar lavage fluid showed that Nrf2 deficiency upregulated TLR4, enhanced I/R-induced lung injury, apoptosis, inflammation, and autophagy, and increased the I/R-induced inactivation of Akt. In mouse lung epithelial cells subjected to oxygen and glucose deprivation/reperfusion (OGD/Rep), Nrf2 silencing increased the OGD/Rep-induced upregulation of TLR4 and MyD88 and downregulation of HO-1, and exacerbated OGD/Rep-induced apoptosis, autophagy, and the downregulation of phospho-Akt. TLR4 silencing and Akt inhibition experiments indicated that OGD/Rep-induced cell death by suppressing Akt signaling, and Nrf2 protected lung cells by modulating TLR4 and Akt signaling. These results indicated that the Nrf2/TLR4/Akt axis plays a role in inflammation-associated lung damage, suggesting potential therapeutic targets for the treatment of lung injury.
Insights
Nuclear factor erythroid 2-related factor 2 (Nrf2) deficiency worsens lung injury by increasing toll-like receptor 4 (TLR4) and impairing Akt signaling. Targeting the Nrf2/TLR4/Akt axis may treat inflammation-associated lung damage.
Area of Science:
- Cellular and Molecular Biology
- Immunology
- Pathology
Background:
- Lung injury is a significant clinical issue linked to systemic inflammation.
- Intestinal ischemia-reperfusion (I/R) injury can trigger lung damage.
- The roles of nuclear factor erythroid 2-related factor 2 (Nrf2) and toll-like receptor 4 (TLR4) in this process require elucidation.
Purpose of the Study:
- To investigate the involvement of Nrf2 and TLR4 in intestinal I/R-induced lung injury.
- To explore the molecular mechanisms underlying Nrf2's protective effects in lung injury models.
Main Methods:
- In vivo studies using Nrf2-knockout mice and I/R models.
- In vitro experiments with mouse lung epithelial cells subjected to oxygen and glucose deprivation/reperfusion (OGD/Rep).
- Techniques included western blotting, immunohistochemistry, TUNEL assay, and analysis of bronchoalveolar lavage fluid.
Main Results:
- Nrf2 deficiency exacerbated I/R-induced lung injury, increasing apoptosis, inflammation, and autophagy.
- Nrf2 deficiency led to TLR4 upregulation and Akt inactivation.
- Nrf2 protected lung cells by modulating TLR4 and Akt signaling pathways.
Conclusions:
- The Nrf2/TLR4/Akt axis is crucial in inflammation-associated lung damage.
- Nrf2 plays a protective role against I/R-induced lung injury.
- This axis represents a potential therapeutic target for lung injury treatment.
Related Concept Videos
Inflammation
PI3K/mTOR/AKT Signaling Pathway
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury V: Interprofessional Care

